Cited by 389Neurotransmitter Receptor Influence on BehaviorNeuropeptides and Animal PhysiologyStress Responses and Cortisol

The DOI matches its Crossref record; 111 of the 112 references it cites were found in a registry or an index.

Brain stress systems in the amygdala and addiction

Open access

Koob, George F.·2009·Brain Research

DOI 10.1016/j.brainres.2009.03.038PMC PMC2774745

Open this paper in CoChat — free account

Abstract

Dysregulation of the brain emotional systems that mediate arousal and stress is a key component of the pathophysiology of drug addiction. Drug addiction is a chronically relapsing disorder characterized by a compulsion to seek and take drugs and the development of dependence and manifestation of a negative emotional state when the drug is removed. Activation of brain stress systems is hypothesized to be a key element of the negative emotional state produced by dependence that drives drug-seeking through negative reinforcement mechanisms. The focus of the present review is on the role of two key brain arousal/stress systems in the development of dependence. Emphasis is placed on the neuropharmacological actions of corticotropin-releasing factor (CRF) and norepinephrine in extrahypothalamic systems in the extended amygdala, including the central nucleus of the amygdala, bed nucleus of the stria terminalis, and a transition area in the shell of the nucleus accumbens. Compelling evidence argues that these brain stress systems, a heretofore largely neglected component of dependence and addiction, play a key role in engaging the transition to dependence and maintaining dependence once it is initiated. Understanding the role of the brain stress and anti-stress systems in addiction not only provides insight into the neurobiology of the "dark side" of addiction but also provides insight into the organization and function of basic brain emotional circuitry that guides motivated behavior.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.brainres.2009.03.038

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
A Syndrome produced by Diverse Nocuous Agents
Selye, H. (1936) · Nature · doi:10.1038/138032a0 · Cited by 3,967
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Self-citation
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Self-citation
Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study
Swanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953
The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress
Smith, S. M., & Vale, W. W. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/ssmith · Cited by 1,948
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Addiction and the brain antireward system
Koob, G. F., & Le Moal, M. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093548 · Cited by 1,457
Self-citation
Allostasis: A New Paradigm to Explain Arousal Pathology
Sterling, P., & Eyer, J. (1988) · Zenodo · doi:10.5281/zenodo.13537700 · Cited by 1,450
Handbook of Life Stress, Cognition and Health
PASTOR, L. H. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.10.1347 · Cited by 1,402
CRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: The striatopallidal, amygdaloid, and corticopetal components of substantia innominata
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056
Self-citation
Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction
Koob, G. F., & Le Moal, M. (2005) · Nature Neuroscience · doi:10.1038/nn1105-1442 · Cited by 963
Self-citation
A Syndrome Produced by Diverse Nocuous Agents
Selye, H. (1998) · Journal of Neuropsychiatry · doi:10.1176/jnp.10.2.230a · Cited by 925
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor
Lewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T. M., Gulyas, J., Fischer, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121165198 · Cited by 925
Urocortin II: A Member of the Corticotropin-Releasing Factor (CRF) Neuropeptide Family that Is Selectively Bound by Type 2 CRF Receptors
Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626398 · Cited by 887
Corticotropin-releasing factor, norepinephrine, and stress
Koob, G. F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00164-x · Cited by 629
Self-citation
Handbook of Life Stress, Cognition and Health
Fisher, S., & REASON, J. T. (1988) · Cited by 575
Further contributions to the study of the evolution of the forebrain
Johnston, J. B. (1923) · Journal of Comparative Neurology · doi:10.1002/cne.900350502 · Cited by 575
Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565
Self-citation
A key role for corticotropin-releasing factor in alcohol dependence
Heilig, M., & Koob, G. F. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.006 · Cited by 503 · cited 1×
“[Modified with permission from Heilig and Koob, 2007.]”
Self-citation
Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal
Rodrı́guez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., & Weiss, F. (1997) · Science · doi:10.1126/science.276.5321.2050 · Cited by 499
Self-citation
Neurobiological substrates for the dark side of compulsivity in addiction
Koob, G. F. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.043 · Cited by 476
Self-citation
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G. (2000) · Nature · doi:10.1038/35000212 · Cited by 462
Compulsive Drug‐Seeking Behavior and Relapse: Neuroadaptation, Stress, and Conditioning Factors
WEISS, F., CICCOCIOPPO, R., PARSONS, L. H., KATNER, S., LIU, X., ZORRILLA, E. P., VALDEZ, G. R., BEN‐SHAHAR, O., ANGELETTI, S., & RICHTER, R. R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03556.x · Cited by 430
Neurobiology of Addiction
(2006) · Neuroscience · doi:10.1016/s0306-4522(05)01473-9 · Cited by 425
Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal
Rassnick, S., Heinrichs, S. C., Britton, K. T., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91352-s · Cited by 407
Self-citation
Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats
Funk, C. K., O'Dell, L. E., Crawford, E. F., & Koob, G. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3096-06.2006 · Cited by 381
Self-citation
International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin-Releasing Factor and Their Ligands
Hauger, R. L., Grigoriadis, D. E., Dallman, M. F., Plotsky, P. M., Vale, W., & Dautzenberg, F. M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.3 · Cited by 365
Additive Effect of Stress and Drug Cues on Reinstatement of Ethanol Seeking: Exacerbation by History of Dependence and Role of Concurrent Activation of Corticotropin-Releasing Factor and Opioid Mechanisms
Liu, X., & Weiss, F. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07856.2002 · Cited by 362
CRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat
Baldwin, H. A., Rassnick, S., Rivier, J., Koob, G. F., & Britton, K. T. (1991) · Psychopharmacology · doi:10.1007/bf02244208 · Cited by 353
Self-citation
Excessive Ethanol Drinking Following a History of Dependence Animal Model of Allostasis
Roberts, A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00167-0 · Cited by 349
Intrinsic GABAergic neurons in the rat central extended amygdala
Sun, N., & Cassell, M. D. (1993) · The Journal of Comparative Neurology · doi:10.1002/cne.903300308 · Cited by 348
Long‐lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol
Rimondini, R., Arlinde, C., Sommer, W. H., & Heilig, M. A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0593com · Cited by 320
Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal
Stinus, L., Le Moal, M., & Koob, G. F. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90106-e · Cited by 317
Self-citation
Amygdaloid Corticotropin‐Releasing Factor Targets Locus Coeruleus Dendrites: Substrate for the Co‐ordination of Emotional and Cognitive Limbs of the Stress Response
Van Bockstaele, E. J., Colago, E. E. O., & Valentino, R. J. (1998) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1998.00254.x · Cited by 311
Piecing together the Puzzle of Basal Forebrain Anatomy
Heimer, L., & Alheid, G. F. (1991) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4757-0145-6_1 · Cited by 310 · cited 3×
“…efferent connections from this complex include the posterior medial (sublenticular) ventral pallidum, ventral tegmental area, various brainstem projections, and perhaps most intriguing from a functional point of view, a considerable projection to the lateral hypothalamus (Heimer and Alheid, 1991).”
Background
Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence
Sommer, W. H., Rimondini, R., Hansson, A. C., Hipskind, P. A., Gehlert, D. R., Barr, C. S., & Heilig, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.010 · Cited by 309
Increased GABA Release in the Central Amygdala of Ethanol-Dependent Rats
Roberto, M., Madamba, S. G., Stouffer, D. G., Parsons, L. H., & Siggins, G. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3004-04.2004 · Cited by 299
The Locus Coeruleus as a Site for Integrating Corticotropin‐Releasing Factor and Noradrenergic Mediation of Stress Responsesa
Valentino, R. J., Foote, S. L., & Page, M. E. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb49931.x · Cited by 292
Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats
Funk, C. K., Zorrilla, E. P., Lee, M.-J., Rice, K. C., & Koob, G. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.063 · Cited by 276
Self-citation
Ethanol Augments GABAergic Transmission in the Central Amygdala via CRF1 Receptors
Nie, Z., Schweitzer, P., Roberts, A. J., Madamba, S. G., Moore, S. D., & Siggins, G. R. (2004) · Science · doi:10.1126/science.1092550 · Cited by 267
Brain corticotropin-releasing factor mediates ‘anxiety-like’ behavior induced by cocaine withdrawal in rats
Sarnyai, Z., Bíró, É., Gardi, J., Vecsernyés, M., Julesz, J., & Telegdy, G. (1995) · Brain Research · doi:10.1016/0006-8993(95)00043-p · Cited by 255
Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor
Valentino, R. J., Page, M. E., & Curtis, A. L. (1991) · Brain Research · doi:10.1016/0006-8993(91)90855-p · Cited by 246
CRF–CRF 1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats
George, O., Ghozland, S., Azar, M. R., Cottone, P., Zorrilla, E. P., Parsons, L. H., O'Dell, L. E., Richardson, H. N., & Koob, G. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707585104 · Cited by 245
Self-citation
A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol Dependence
Mason, B. J., Ritvo, E. C., Morgan, R. O., Salvato, F., Goldberg, G., Welch, B., & Mantero-Atienza, E. (1994) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb00098.x · Cited by 243
Urocortin III-Immunoreactive Projections in Rat Brain: Partial Overlap with Sites of Type 2 Corticotrophin-Releasing Factor Receptor Expression
Li, C., Vaughan, J. M., Sawchenko, P. E., & Vale, W. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00991.2002 · Cited by 241
3-(4-Chloro-2-Morpholin-4-yl-Thiazol-5-yl)-8-(1-Ethylpropyl)-2,6-Dimethyl-Imidazo[1,2-b]Pyridazine: A Novel Brain-Penetrant, Orally Available Corticotropin-Releasing Factor Receptor 1 Antagonist with Efficacy in Animal Models of Alcoholism
Gehlert, D. R., Cippitelli, A., Thorsell, A., Lê, A. D., Hipskind, P. A., Hamdouchi, C., Lu, J., Hembre, E. J., Cramer, J. W., Song, M., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4985-06.2007 · Cited by 239
Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake
Olive, M. F., Koenig, H. N., Nannini, M. A., & Hodge, C. W. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00748-1 · Cited by 237
STRESS, AROUSAL, AND THE PITUITARY-ADRENAL SYSTEM: A PSYCHOENDOCRINE HYPOTHESIS
Hennessy, J. W., & Levine, S. (1979) · Cited by 237
The Stress Response: A New Perspective
Burchfield, S. R. (1979) · Psychosomatic Medicine · doi:10.1097/00006842-197912000-00008 · Cited by 233
Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal
Heinrichs, S. C., Menzaghi, F., Schulteis, G., Koob, G. F., & Stinus, L. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199501000-00011 · Cited by 226
Self-citation
In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats
Richter, R. M., & Weiss, F. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990615)32:4 · Cited by 210
Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats
Basso, A. M., Spina, M. G., Rivier, J., Vale, W., & Koob, G. F. (1999) · Psychopharmacology · doi:10.1007/s002130051028 · Cited by 190
Self-citation
High-priority communication I Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence
Valdez, G. R., Zorrilla, E. P., Roberts, A. J., & Koob, G. F. (2003) · Alcohol · doi:10.1016/s0741-8329(03)00020-x · Cited by 186
Self-citation
α1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol
Walker, B. M., Rasmussen, D. D., Raskind, M. A., & Koob, G. F. (2008) · Alcohol · doi:10.1016/j.alcohol.2007.12.002 · Cited by 170
Self-citation
The basal forebrain : anatomy to function
Napier, T. C., Kalivas, P. W., & Hanin, I. (1991) · Plenum Press eBooks · Cited by 169
Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors
Overstreet, D. H. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.11.010 · Cited by 169
Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis
Kash, T. L., & Winder, D. G. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.06.011 · Cited by 166
Neurobiology of addiction
Chou, I.-H., & Narasimhan, K. (2005) · Nature Neuroscience · doi:10.1038/nn1105-1427 · Cited by 162
Replication and extension of Marlatt's taxonomy of relapse precipitants: overview of procedures and results
Lowman, C., Allen, J., & Stout, R. L. (1996) · Addiction · doi:10.1111/j.1360-0443.1996.tb02327.x · Cited by 157
α1-Noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access
Wee, S., Mandyam, C. D., Lekić, D., & Koob, G. F. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.08.003 · Cited by 140
Self-citation
Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats
Stinus, L., Cador, M., Zorrilla, E. P., & Koob, G. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300487 · Cited by 139
Self-citation
Alcohol withdrawal symptoms and drinking behavior.
Hershon, H. I. (1977) · Journal of Studies on Alcohol · doi:10.15288/jsa.1977.38.953 · Cited by 139
Noradrenaline Triggers GABAAInhibition of Bed Nucleus of the Stria Terminalis Neurons Projecting to the Ventral Tegmental Area
Dumont, É. C., & Williams, J. T. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0425-04.2004 · Cited by 137
Molecular and cellular mechanisms of opiate action: Studies in the rat locus coeruleus
Nestler, E. J., Alreja, M., & Aghajanian, G. K. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90166-x · Cited by 136
CRF1 receptor antagonists attenuate escalated cocaine self-administration in rats
Specio, S. E., Wee, S., O’Dell, L. E., Boutrel, B., Zorrilla, E. P., & Koob, G. F. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0983-9 · Cited by 132
Self-citation
Increased Anxiety‐Like Behavior and Ethanol Self‐Administration in Dependent Rats: Reversal via Corticotropin‐Releasing Factor‐2 Receptor Activation
Valdez, G. R., Sabino, V., & Koob, G. F. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000128222.29875.40 · Cited by 131
Self-citation
Immunocytochemical evidence for stimulatory control by the ventral noradrenergic bundle of parvocellular neurons of the paraventricular nucleus secreting corticotropin releasing hormone and vasopressin in rats
Alonso, G., SZAFARCZYK, A., Balmefrézol, M., & ASSENMACHER, I. (1986) · Brain Research · doi:10.1016/0006-8993(86)90631-1 · Cited by 130
SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats
Knapp, D. J., Overstreet, D. H., Moy, S. S., & Breese, G. R. (2004) · Alcohol · doi:10.1016/j.alcohol.2003.08.007 · Cited by 130
Brain-Derived Neurotrophic Factor Is Essential for Opiate-Induced Plasticity of Noradrenergic Neurons
Akbarian, S., Rios, M., Liu, R.-J., Gold, S. J., Fong, H., Zeiler, S., Coppola, V., Tessarollo, L., Jones, K. R., Nestler, E. J., et al. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-10-04153.2002 · Cited by 129
Modifications in the response to alcohol following the establishment of physical dependence
Branchey, M. H., Rauscher, G., & Kissin, B. (1971) · Psychopharmacology · doi:10.1007/bf00406870 · Cited by 126
Alcohol Withdrawal Syndromes: Clinical Management with Lofexidine
Cushman, P., Forbes, R., Lemer, W., & Stewart, M. (1985) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1985.tb05527.x · Cited by 125
Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist
Breese, G. R., Overstreet, D. H., Knapp, D. J., & Navarro, M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300706 · Cited by 124
Relapse research and the Reasons for Drinking Questionnaire: a factor analysis of Marlatt’s relapse taxonomy
ZYWIAK, W. H., CONNORS, G. J., MAISTO, S. A., & WESTERBERG, V. S. (1996) · Addiction · doi:10.1111/j.1360-0443.1996.tb02332.x · Cited by 121
β-adrenergic antagonists attenuate withdrawal anxiety in cocaine-and morphine-dependent rats
Harris, G. C., & Aston‐Jones, G. (1993) · Psychopharmacology · doi:10.1007/bf02244345 · Cited by 118
Positive relationship between the number of prior ethanol withdrawal episodes and the severity of subsequent withdrawal seizures
Becker, H. C. (1994) · Psychopharmacology · doi:10.1007/bf02244867 · Cited by 118
Brain arousal and information theory: neural and genetic mechanisms
(2006) · Choice Reviews Online · doi:10.5860/choice.43-5280 · Cited by 116
Hyperventilation, anxiety, craving for alcohol: A subacute alcohol withdrawal syndrome
Roelofs, S. M. G. J. (1985) · Alcohol · doi:10.1016/0741-8329(85)90123-5 · Cited by 114
Central Norepinephrine Metabolism During Alcohol Intoxication in Addicts and Healthy Volunteers
Borg, S., Kvande, H., & Sedvall, G. (1981) · Science · doi:10.1126/science.7268421 · Cited by 113
Ethanol-Associated Behaviors of Mice Lacking Norepinephrine
Weinshenker, D., Rust, N. C., Miller, N. S., & Palmiter, R. D. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03157.2000 · Cited by 99
MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist
RICHARDSON, H., ZHAO, Y., Fekete, É. M., FUNK, C., Wirsching, P., Janda, K. D., Zorrilla, E. P., & Koob, G. F. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.10.008 · Cited by 95
Self-citation
Allostatic view of motivation: implications for psychopathology.
Koob, G. F. (2004) · PubMed · Cited by 89
Self-citation
PRECLINICAL STUDY: Corticotropin‐releasing factor‐1 receptor antagonists decrease heroin self‐administration in long‐ but not short‐access rats
Greenwell, T. N., Funk, C. K., Cottone, P., Richardson, H. N., Chen, S. A., Rice, K. C., Zorrilla, E. P., & Koob, G. F. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00142.x · Cited by 87
Self-citation
INSIGHTS FROM IN VIVO MODIFICATION OF ADRENERGIC RECEPTOR GENE EXPRESSION
Rohrer, D. K., & Kobilka, B. K. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.351 · Cited by 76
Studies on duration of a late recovery period after chronic abuse of ethanol
Alling, C., Balldin, J., Bokström, K., Gottfries, C. G., Karlsson, I., & Långström, G. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb06720.x · Cited by 75
Detection by in vivo microdialysis of nicotine-induced norepinephrine secretion from the hypothalamic paraventricular nucleus of freely moving rats: dose-dependency and desensitization
Sharp, B. M., & Matta, S. G. (1993) · Endocrinology · doi:10.1210/endo.133.1.8391419 · Cited by 74
Gender in relation to relapse crisis situations, coping, and outcome among treated alcoholics
Annis, H. M., Sklar, S. M., & Moser, A. E. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(97)00024-5 · Cited by 72
The effects of selective catecholamine depletions by 6-hydroxydopamine on ethanol preference in rats
Brown, Z. W., & Amit, Z. (1977) · Neuroscience Letters · doi:10.1016/0304-3940(77)90109-4 · Cited by 69
The α1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration
Greenwell, T. N., Walker, B. M., Cottone, P., Zorrilla, E. P., & Koob, G. F. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.07.012 · Cited by 69
Self-citation
Noradrenergic mediation of the positive reinforcing properties of ethanol: I. Suppression of ethanol consumption in laboratory rats following dopamine-beta-hydroxylase inhibition.
Amit, Z., Zw, B., Levitan, D. E., & Ögren, S. O. (1977) · PubMed · Cited by 68
Norepinephrine Secretion in the Hypothalamic Paraventricular Nucleus of Rats during Unlimited Access to Self-Administered Nicotine: An In Vivo Microdialysis Study
Fu, Y., Matta, S. G., Brower, V. G., & Sharp, B. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-22-08979.2001 · Cited by 66
Motivational factors in the etiology of drug abuse
Bevins, R. A., Bardo, M. T., & Koob, G. F. (2004) · Cited by 65
Self-citation
Potentiation of ethanol withdrawal by prior dependence
Baker, T. B., & Cannon, D. S. (1979) · Psychopharmacology · doi:10.1007/bf00432279 · Cited by 64
Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior
Slawecki, C. J., Thorsell, A. K., Khoury, A. E., Mathé, A. A., & Ehlers, C. L. (2005) · Neuropeptides · doi:10.1016/j.npep.2005.06.002 · Cited by 64
Clinical Conditions and Concentrations of MOPEG in the Cerebrospinal Fluid and Urine of Male Alcoholic Patients during Withdrawal
Borg, S., Czarnecka, A., Kvande, H., Mossberg, D., & Sedvall, G. (1983) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1983.tb05496.x · Cited by 46
Distribution of corticotropin-releasing factor-like immunoreactivity in human brain
Charlton, B. G., Ferrier, I. N., & Perry, R. H. (1987) · Neuropeptides · doi:10.1016/s0143-4179(87)90083-7 · Cited by 44
Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
Fujimoto, A., Nagao, T., Ebara, T., Sato, M., & Otsuki, S. (1983) · PubMed · Cited by 40
PRECLINICAL STUDY: Long‐lasting tolerance to alcohol following a history of dependence
Rimondini, R., Sommer, W. H., Dall’Olio, R., & Heilig, M. A. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00079.x · Cited by 40
Corticotropin releasing factor antagonist, α-helical CRF9–41, reverses nicotine-induced conditioned, but not unconditioned, anxiety
Tucci, S., Cheeta, S., Seth, P., & File, S. E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1403-4 · Cited by 38
Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats
Schulteis, G. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00036-0 · Cited by 37
Norepinephrine release in amygdala of rats during chronic nicotine self-administration: an in vivo microdialysis study
Fu, Y. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00201-6 · Cited by 36
Neurotrophin-3 modulates noradrenergic neuron function and opiate withdrawal
Akbarian, S., Bates, B., Liu, R.-J., Skirboll, S. L., Pejchal, T., Coppola, V., Sun, L. D., Fan, G., Kučera, J., Wilson, M. A., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000897 · Cited by 36
Nicotinic activation of CRH neurons in extrahypothalamic regions of the rat brain
Matta, S. G., Valentine, J. D., & Sharp, B. M. (1997) · Endocrine · doi:10.1007/bf02778147 · Cited by 35
Ethanol consumption and reward depend on norepinephrine in the prefrontal cortex
Ventura, R., Carolis, D. D., Alcaro, A., & Puglisi‐Allegra, S. (2006) · Neuroreport · doi:10.1097/01.wnr.0000239964.83566.75 · Cited by 33
Reinforcement with intragastric infusions of ethanol: Blocking effect of FLA 57
Davis, W. M., Werner, T. E., & Smith, S. G. (1979) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(79)90038-8 · Cited by 31
Noradrenaline and ethanol intake in the rat
Mason, S. T., Corcoran, M. E., & Fibiger, H. C. (1979) · Neuroscience Letters · doi:10.1016/0304-3940(79)91494-0 · Cited by 28
Ethanol-induced locomotor stimulation in C57BL/6 mice following RO15-4513 administration
Becker, H. C., & Hale, R. L. (1989) · Psychopharmacology · doi:10.1007/bf00445553 · Cited by 24
The roles of urocortins 1, 2, and 3 in the brain
Zorrilla, E. P., & Koob, G. F. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80013-6 · Cited by 11
Self-citation
Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: Evidence for their selective activation by interleukin-1?
Day, H. E. W., Curran, E. J., Watson, S. J., & Akil, H. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19991011)413:1

Flagged first, then by citations

1 of the 112 references couldn’t be matched to a known paper.

Sorted by citations

Neurocircuitry of Addiction
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Self-citation
Rethinking the Emotional Brain
LeDoux, J. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.004 · Cited by 1,594
“…1980; Balleine and Killcross, 1994; Killcross and Robbins, 1993; Everitt et al., 1999; Cardinal et al., 2002; Ikemoto and Panksepp, 1999; Parkinson et al., 1999; Koob, 2009; Sesack and Grace, 2010; Berridge, 2007, 2009; Berridge and Robinson, 1998; Hyman et al., 2006; Nestler, 2004; Kelley, 2004).”
Amygdala circuitry mediating reversible and bidirectional control of anxiety
Tye, K. M., Prakash, R., Kim, S.-Y., Fenno, L. E., Grosenick, L., Zarabi, H., Thompson, K. R., Gradinaru, V., Ramakrishnan, C., & Deisseroth, K. (2011) · Nature · doi:10.1038/nature09820 · Cited by 1,289
Stress-induced obesity and the emotional nervous system
Dallman, M. F. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.10.004 · Cited by 814
Impulsivity, frontal lobes and risk for addiction
Crews, F. T., & Boettiger, C. A. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.04.018 · Cited by 679
“Impulsive choice is one aspect of impulsivity that involves the choice of small, sooner rewards over larger, delayed rewards (Cardinal et al., 2004).”
Background

See all 389

Authors: Koob, G. F.
Affiliations: Scripps Research Institute (US)
Corresponding author: Koob, George F.
ORCID: Koob, George F.
Venue: Brain Research
Publisher: Elsevier BV
Published: 2009-10
Volume: 1293
Pages: 61-75
ISSN: 0006-8993 (ISSN-L)
DOI: 10.1016/j.brainres.2009.03.038
PMC: PMC2774745
OpenAlex: W2010555262
Cited by: 388
References: 112
Citations by year: 2026: 11 · 2025: 10 · 2024: 22 · 2023: 17 · 2022: 20 · 2021: 24 · 2020: 31 · 2019: 33 · 2018: 34 · 2017: 20 · 2016: 25 · 2015: 28 · 2014: 24 · 2013: 24 · 2012: 20
FWCI: 1.88
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Brain Research (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism (R01AA008459, AA-06420, AA-08459, P50AA006420, R37AA008459, P60AA006420)
National Institute on Drug Abuse (DA04043, DA04398, R01DA004398, R01DA004043)
National Institute of Diabetes and Digestive and Kidney Diseases (DK 26741, P01DK026741)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords: drug addiction, extended amygdala, corticotropin-releasing factor, norepinephrine, central amygdala, bed nucleus of the stria terminalis, nucleus accumbens shell, negative reinforcement, emotional arousal, relapse, motivated behavior
MeSH terms: Amygdala, Animals, Compulsive Behavior, Corticotropin-Releasing Hormone, Humans, Hypothalamo-Hypophyseal System, Motivation, Norepinephrine, Pituitary-Adrenal System, Stress, Psychological, Substance Withdrawal Syndrome, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Brain stress systems in the amygdala and addiction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks